These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35954409)

  • 1. Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer Patients.
    Hess J; Unger K; Maihoefer C; Schüttrumpf L; Weber P; Marschner S; Wintergerst L; Pflugradt U; Baumeister P; Walch A; Woischke C; Kirchner T; Werner M; Sörensen K; Baumann M; Tinhofer I; Combs SE; Debus J; Schäfer H; Krause M; Linge A; von der Grün J; Stuschke M; Zips D; Canis M; Lauber K; Ganswindt U; Henke M; Zitzelsberger H; Belka C
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection.
    Hess J; Unger K; Maihoefer C; Schüttrumpf L; Wintergerst L; Heider T; Weber P; Marschner S; Braselmann H; Samaga D; Kuger S; Pflugradt U; Baumeister P; Walch A; Woischke C; Kirchner T; Werner M; Werner K; Baumann M; Budach V; Combs SE; Debus J; Grosu AL; Krause M; Linge A; Rödel C; Stuschke M; Zips D; Zitzelsberger H; Ganswindt U; Henke M; Belka C
    Clin Cancer Res; 2019 Mar; 25(5):1505-1516. PubMed ID: 30171046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
    Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
    Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Linge A; Lohaus F; Löck S; Nowak A; Gudziol V; Valentini C; von Neubeck C; Jütz M; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Buchholz F; Aust DE; Baretton GB; Thames HD; Dubrovska A; Alsner J; Overgaard J; Krause M; Baumann M;
    Radiother Oncol; 2016 Dec; 121(3):364-373. PubMed ID: 27913065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC.
    Linge A; Schötz U; Löck S; Lohaus F; von Neubeck C; Gudziol V; Nowak A; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Bunea H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Lauber K; Pigorsch S; Combs SE; Mönnich D; Zips D; Baretton GB; Buchholz F; Krause M; Belka C; Baumann M;
    Radiother Oncol; 2018 Apr; 127(1):27-35. PubMed ID: 29295747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a 6-gene signature for the prognosis of loco-regional control in patients with HPV-negative locally advanced HNSCC treated by postoperative radio(chemo)therapy.
    Patil S; Linge A; Grosser M; Lohaus F; Gudziol V; Kemper M; Nowak A; Haim D; Tinhofer I; Budach V; Guberina M; Stuschke M; Balermpas P; Rödel C; Schäfer H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Boeke S; Zips D; Baretton GB; Baumann M; Krause M; Löck S;
    Radiother Oncol; 2022 Jun; 171():91-100. PubMed ID: 35429503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).
    Balermpas P; Rödel F; Rödel C; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Gkika E; Stuschke M; Avlar M; Grosu AL; Abdollahi A; Debus J; Bayer C; Stangl S; Belka C; Pigorsch S; Multhoff G; Combs SE; Mönnich D; Zips D; Fokas E
    Int J Cancer; 2016 Jan; 138(1):171-81. PubMed ID: 26178914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    Li J; Tang LL; Ma J
    BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - Hypothesis generation on a multicentre cohort of the DKTK-ROG.
    Löck S; Linge A; Lohaus F; Ebert N; Gudziol V; Nowak A; Tinhofer I; Kalinauskaite G; Guberina M; Stuschke M; Balermpas P; von der Grün J; Grosu AL; Debus J; Ganswindt U; Belka C; Peeken JC; Combs SE; De-Colle C; Zips D; Baretton GB; Krause M; Baumann M;
    Radiother Oncol; 2022 Apr; 169():8-14. PubMed ID: 35182686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapy.
    Patil S; Tawk B; Grosser M; Lohaus F; Gudziol V; Kemper M; Nowak A; Haim D; Tinhofer I; Budach V; Guberina M; Stuschke M; Balermpas P; Rödel C; Schäfer H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Boeke S; Zips D; Baretton GB; Baumann M; Krause M; Löck S; Linge A;
    Radiother Oncol; 2022 Feb; 167():300-307. PubMed ID: 34999136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy.
    Tawk B; Wirkner U; Schwager C; Rein K; Zaoui K; Federspil PA; Adeberg S; Linge A; Ganswindt U; Hess J; Unger K; Tinhofer I; Budach V; Lohaus F; Krause M; Guberina M; Stuschke M; Balermpas P; Rödel C; Grosu AL; Schäfer H; Zips D; Combs SE; Pigorsch S; Zitzelsberger H; Baumeister P; Kirchner T; Bewerunge-Hudler M; Weichert W; Hess J; Herpel E; Belka C; Baumann M; Debus J; Abdollahi A;
    Int J Cancer; 2022 Feb; 150(4):603-616. PubMed ID: 34648658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
    Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas.
    Hakima L; Adler E; Prystowsky M; Schiff B; Schlecht N; Fox A; Suhrland M; Khader SN
    Diagn Cytopathol; 2015 Sep; 43(9):683-7. PubMed ID: 25964135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of HPV in Mexican Patients with Head and Neck Squamous Carcinoma and Identification of Potential Prognostic Biomarkers.
    Méndez-Matías G; Velázquez-Velázquez C; Castro-Oropeza R; Mantilla-Morales A; Ocampo-Sandoval D; Burgos-González A; Heredia-Gutiérrez C; Alvarado-Cabrero I; Sánchez-Sandoval R; Barco-Bazán A; Chilaca-Rosas F; Piña-Sánchez P
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Balermpas P; Rödel F; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Sak A; Stuschke M; Gkika E; Grosu AL; Abdollahi A; Debus J; Stangl S; Ganswindt U; Belka C; Pigorsch S; Multhoff G; Combs SE; Welz S; Zips D; Lim SY; Rödel C; Fokas E;
    Int J Cancer; 2017 Aug; 141(3):594-603. PubMed ID: 28480996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status.
    Coordes A; Lenz K; Qian X; Lenarz M; Kaufmann AM; Albers AE
    Eur Arch Otorhinolaryngol; 2016 Aug; 273(8):2157-69. PubMed ID: 26227616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic and Molecular Profiling of Human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Blockade Compared to Survival Outcomes.
    Shaikh H; McGrath JE; Hughes B; Xiu J; Brodskiy P; Sukari A; Darabi S; Ikpeazu C; Nabhan C; Korn WM; Wise-Draper TM
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
    Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p16, p53, and TLR9 in HPV-Associated Head and Neck Squamous Cell Carcinoma: Clinicopathological Correlations and Potential Prognostic Significance.
    Wang S; Zhuang X; Gao C; Qiao T
    Onco Targets Ther; 2021; 14():867-877. PubMed ID: 33574680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.